propranolol has been researched along with Cholangitis, Sclerosing in 2 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Cholangitis, Sclerosing: Chronic inflammatory disease of the BILIARY TRACT. It is characterized by fibrosis and hardening of the intrahepatic and extrahepatic biliary ductal systems leading to bile duct strictures, CHOLESTASIS, and eventual BILIARY CIRRHOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease leading to cirrhosis and cholangiocellular carcinoma." | 1.39 | Telmisartan plus propranolol improves liver fibrosis and bile duct proliferation in the PSC-like Abcb4-/- mouse model. ( Demir, M; Dienes, HP; Goeser, T; Hunt, H; Mende, S; Nierhoff, D; Odenthal, M; Pryymachuck, G; Quasdorff, M; Schulte, S; Steffen, HM; Strack, I; Töx, U, 2013) |
| "Propranolol treatment of Mdr2(-/-) mice improved liver architecture." | 1.37 | β-Adrenoceptor blockade in sclerosing cholangitis of Mdr2 knockout mice: antifibrotic effects in a model of nonsinusoidal fibrosis. ( Dienes, HP; Drebber, U; Odenthal, M; Schievenbusch, S; Schulte, S; Steffen, HM; Strack, I; Töx, U; Varnholt, H; Wendland, K, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strack, I | 2 |
| Schulte, S | 2 |
| Varnholt, H | 1 |
| Schievenbusch, S | 1 |
| Töx, U | 2 |
| Wendland, K | 1 |
| Steffen, HM | 2 |
| Drebber, U | 1 |
| Dienes, HP | 2 |
| Odenthal, M | 2 |
| Mende, S | 1 |
| Hunt, H | 1 |
| Pryymachuck, G | 1 |
| Quasdorff, M | 1 |
| Demir, M | 1 |
| Nierhoff, D | 1 |
| Goeser, T | 1 |
2 other studies available for propranolol and Cholangitis, Sclerosing
| Article | Year |
|---|---|
β-Adrenoceptor blockade in sclerosing cholangitis of Mdr2 knockout mice: antifibrotic effects in a model of nonsinusoidal fibrosis.
Topics: Actins; Adrenergic beta-Antagonists; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Bin | 2011 |
Telmisartan plus propranolol improves liver fibrosis and bile duct proliferation in the PSC-like Abcb4-/- mouse model.
Topics: Adrenergic beta-Antagonists; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cas | 2013 |